Fabrizio D'Abate, London, United Kingdom. Haemodynamic assessment of venous ... Rick de Graaf, Maastricht, Netherlands.
Vascular & Endovascular
Consensus Update Pathways of Care
CONTROVERSIES
CHALLENGES
CONSENSUS
CX Venous Programme 25–28 APRIL 2017, OLYMPIA GRAND, LONDON, UK ORGANISING BOARD: Ian Franklin, Stephen Black, Alun Davies and Andrew Bradbury
Peripheral Arterial Consensus
Aortic Consensus
Acute Stroke Consensus
Venous Consensus
25 APRIL
26–27 APRIL
28 APRIL
CX Venous Consensus Update – Plenary Programme
CX Venous Workshop NEW CX Venous Edited Cases
CX Venous Abstracts
Register at WWW.CXSYMPOSIUM.COM Early bird registration ends: 26 February 2017
EDUCATION
[email protected]
INNOVATION EVIDENCE CX Symposium
@cxsymposium
CX Venous Consensus Update – Plenary Programme 25 April 2017, Lower Main Auditorium
Investigations of superficial and deep venous anatomy WHETHER to intervene
The best imaging modality – the implication of cost Alun Davies, London, United Kingdom Computed tomography (CT) venography and magnetic resonance (MR) venography are performed in the horizontal position – suitability for assessing venous function Andrew Wigham, Oxford, United Kingdom Value of fusion imaging to treat deep venous thrombosis Adrien Hertault, Lille, France
The place of ultrasound for deep venous assessment Fabrizio D'Abate, London, United Kingdom Haemodynamic assessment of venous reflux and obstruction Andrew Nicolaides, London, United Kingdom
WHEN to intervene INTERVENTION METHOD Assessment and intervention of acute and chronic disease of the deep venous system
Why are so many venous stents deployed for swollen legs? Lowell Kabnick, New York, United States
Pathways of care for venous stenting interventions Manj Gohel, Cambridge, United Kingdom Best medical and pharmacological treatment for post-thrombotic syndrome Arkadiusz Jawien, Bydgoszcz, Poland Treatment for acute deep venous thrombosis – pathways of care on the use of catheter-directed thrombolysis and mechanical thrombectomy Rick de Graaf, Maastricht, Netherlands
Pelvic vein congestion and reflux
Prevalence of pelvic vein venous reflux and criteria for treatment Kathleen Gibson, Bellevue, United States Prevalence of pelvic vein incompetence in women with chronic pelvic pain and influence on quality of life – scoring systems Charles McCollum, Manchester, United Kingdom
Predictors of recanalisation after cyanoacrylate truncal vein treatment Yiu Che Chan, Hong Kong Biomatrix sclerofoam as a rival for endothermal ablation Johann Christof Ragg, Berlin, Germany Mechanochemical ablation of varicose veins – present evidence and indications Steve Elias, Englewood, United States Anti-venous thrombosis protocol – new scoring system Isaac Nyamekye, Worcester, United Kingdom A compression system to improve working compression pressure Torbjorn Lundh, Gothenburg, Sweden Endovenous adhesive occlusion for advanced superficial venous disease – WAVES study data at 12 months Kathleen Gibson, Bellevue, United States TEA
Industry Sponsored Satellite
VIVO – EU stent results for symptomatic iliofemoral venous outflow obstruction Narayan Karunanithy, London, United Kingdom Early clot removal and stenting
Michael Lichtenberg, Arnsberg, Germany
Complex endovascular inferior vena cava reconstruction Nils Kucher, Bern, Switzerland Cost-effectiveness of intervention for acute and chronic deep vein thrombosis Andrew Bradbury, Birmingham, United Kingdom Deep venous stenting for chronic venous disease – stenting of the iliac tract Erin Murphy, Jackson, United States
WHETHER to intervene WHEN to intervene INTERVENTION METHOD FOLLOW-UP
Foam sclerotherapy for reticular veins and telangiectasia Claudine Hamel-Desnos, Caen, France
See more on www.cxsymposium.com
Patient choice in deploying a deep venous stent Ramon Varcoe, Sydney, Australia
Aesthetic phlebology
Optimising cosmetic outcomes for reticular veins and telangiectasia Albert-Adrien Ramelet, Montcherand, Switzerland
COFFEE
INTERVENTION METHOD and outcomes
Endovenous adhesive vs. radiofrequency ablation at three years – VeClose study Nick Morrison, Scottsdale, United States
ATTRACT trial – medical treatment versus intervention (catheter-directed thrombolysis or mechanical thrombectomy) Suresh Vedantham, Saint Louis, United States
Varicose vein management
VERNACULAR iliac venous stent study
Rick de Graaf, Maastricht, Netherlands
Use of deep venous stents – flexibility versus strength Stephen Black, London, United Kingdom Decision-making in the choice of anticoagulants and length of treatment following deep venous stenting Adam Gwozdz, London, United Kingdom Endophlebectomy and fistula – necessity and at what risk Houman Jalaie, Aachen, Germany
Lymphoedema
WHETHER to intervene
Modern understanding of primary lymphatic dysplasias and prognosis Sahar Mansour, London, United Kingdom Overview of lymphatic imaging techniques John Rasmussen, Houston, United States Surgical procedures for lymphoedema
Aina Greig, London, United Kingdom
Leg ulceration
INTERVENTION METHOD and outcomes
Modern guidelines for leg ulceration
Keith Poskitt, Cheltenham, United Kingdom
Biological strategies for wound healing Muholan Kanapathy, London, United Kingdom Pathways of care – early venous reflux ablation (EVRA) Manj Gohel, Cambridge, United Kingdom
The current role for the use of inferior vena cava filters – indications and contraindications Gerard Goh, Melbourne, Australia LUNCH
Industry Sponsored Satellite
Visit hands-on techniques
See more on www.cxsymposium.com
Upper limb/subclavian vein compression
Conservative treatment of Paget Schrötter syndrome Kaj Johansen, Seattle, United States Treatment of subclavian vein compression/central veins occlusions Narendra Nath Khanna, New Delhi, India
This preliminary CX Venous Programme is subject to change
EDUCATION
INNOVATION EVIDENCE
For more information visit www.cxsymposi
[email protected]
CX Symposium
@cxsymposium
CX Venous Workshop 26–27 April 2017, Venous City (Exhibition level) The CX Venous Workshop is the longest running and one of the largest of its kind in the world. It is part of the fourday CX Venous Programme of the Charing Cross Symposium and expands on the technical aspects of key topics from the CX Venous Main Programme. On days two and three of the CX Symposium, the CX Venous Workshop offers one-to-one demonstrations by world-leading experts on various superficial and deep venous interventions at dedicated training stations including:
• • • • • • • • • • • • •
cute DVT imaging and clot ageing A Acute DVT interventions Acute venous thrombosis Aesthetic phlebology Air plethysmography and haemodynamic assessment of lower limb outflow Ambulatory phlebectomy Caval filters CHIVA Comparison of CT, MR and IVUS for planning deep vein interventions Compression techniques – NEW Compression film bandage for foam sclerotherapy – NEW Deep vein stenting Diagnostic venous ultrasound
• Foam phlebectomy • Foam sclerotherapy • Investigation for occult malignancy after acute DVT • IVUS • Labial and pudendal veins • Lymphoedema • Neovalve construction surgery in PTS – NEW • Neuromuscular electrical stimulation • Non-thermal ablation • Paget Schroetter syndrome • Pelvic vein reflux • Restless leg syndrome – NEW • Ruscus extract for chronic venous disease – NEW
• Steam thermotherapy • Sulodexide for prevention of postthrombotic syndrome – NEW • Superficial venous thrombophlebitis management • Surgical skills • Surgical deep venous reconstructions • Thermal – radiofrequency • Thermal – laser • Treatment of perforator veins • Ultrasound City
• Valve technologies • Vascular ultrasound training simulator • Venous embryology and anatomy and virtual reality teaching
The comprehensive CX Venous Programme also includes: NEW CX Venous Edited Cases
CX Venous Abstracts
26‒27 April 2017, Venous City (Exhibition level)
28 April 2017, CX Learning Centres
For the first time, edited cases on venous intervention will be presented as part of the CX Venous Programme on days two and three of the CX Symposium.
Senior and trainee physicians will present over 30 abstracts in the venous field.
What participants say about the CX Venous Programme 2016 – CME feedback “The CX Venous Programme provides a very good update on the everchanging venous therapies. I will be introducing some into my practice” “I enjoyed the deep venous session. It was well organised, well attended and well debated. This highlights the growing importance of this aspect of vascular surgery” “I really enjoyed the CX Venous Workshop. I found out about the use of the newest devices for superficial and deep venous treatment” This preliminary CX Venous Programme is subject to change
ium.com or email
[email protected]
EDUCATION
[email protected]
INNOVATION EVIDENCE CX Symposium
@cxsymposium
Invited CX Venous Programme Faculty
Evi Kalodiki, London, UK
Stephen Black, London, UK
John Rasmussen, Houston, USA
Tristan Lane, London, UK
Andrew Bradbury, Birmingham, UK
Ramon Varcoe, Sydney, Australia
Christopher Lattimer, London, UK
Yiu-Che Chan, Hong Kong
Suresh Vedantham, Saint Louis, USA
Patrick Lintott, High Wycombe, UK
Fabrizio D’Abate, London, UK
Andrew Wigham, Oxford, UK
Constantinos Kyriakides, London, UK
Anthony Lopez, London, UK Oliver Lyons, London, UK
Alun Davies, London, UK Ian Franklin, London, UK Rick de Graaf, Maastricht, Netherlands Steve Elias, Englewood, USA Kathleen Gibson, Bellevue, USA Gerard Goh, Melbourne, Australia Manj Gohel, Cambridge, UK Aina Greig, London, UK Adam Gwozdz, London, UK
Francis Matthey, London, UK Vickie McDonald, London, UK
Additional CX Venous Workshop demonstrators
Andrew McIrvine, London, UK David McLain, Newport, UK Matthew Metcalfe, Stevenage, UK Kasuo Miyake, São Paulo, Brazil
Simon Ashley, Plymouth, UK
Hayley Moore, London, UK
Mustapha Azzam, London, UK
Peter Mortimer, London, UK
Gareth Bate, Birmingham,UK
Sriram Narayanan, Singapore
Dan Carradice, Hull, UK
Vikas Pandey, London, UK
Claudine Hamel-Desnos, Caen, France
Eddie Chaloner, London, UK
Adrien Hertault, Lille, France
Sylvain Chastanet, Nice, France
Houman Jalaie, Aachen, Germany
Ian Chetter, Hull, UK
Arkadiusz Jawien, Bydgoszcz, Poland
Shakila Chowdhury, London, UK
Kaj Johansen, Seattle, USA
Joannis Constantinides, London, UK
Lowell Kabnick, New York, USA
Michael Cumming, St. Louis Park, USA
Switzerland
Muholan Kanapathy, London, UK
Lizzie Curry, Stoke-on-Trent, UK
Hema Rao, London, UK
Katy Darvall, Taunton, UK
Sudip Ray, London, UK
Saroj Das, London, UK
Sophie Renton, London, UK
Huw Davies, Birmingham, UK
Alex Rodway, Redhill, UK
Brahman Dharmarajah, London, UK
Prakash Saha, London, UK
Karen Dhillon, London, UK
John Scurr, London, UK
Mary Ellis, London, UK
Joseph Shalhoub, London, UK
Jawed Fareed, Maywood, USA
Amanda Shepherd, London, UK
Charles McCollum, Manchester, UK
Claude Franceschi, Paris, France
Ravi Singh-Ranger, Cirencester, UK
Nick Morrison, Scottsdale, USA
Greg Fulton, Wilton, Ireland
Gerry Stansby, Newcastle-upon-Tyne, UK
Erin Murphy, Jackson, USA
Raghvinder Gambhir, London, UK
Alexey Sukhanov, Moscow, Russia
Andrew Nicolaides, London, UK
Margaret Gardner, Ashtead, UK
John Thompson, Exeter, UK
Isaac Nyamekye, Worcester, UK
Panos Gkoutzios,
Stephen Tristram, Basingstoke, UK
Keith Poskitt, Cheltenham, UK
Judy Holdstock, Guildford, UK
Jean-Francois Uhl, Paris, France
Rajesh Hydrabadi, Ahmedabad, India
Angela Williams, London, UK
Usman Jaffer, London, UK
Katherine Williams, London, UK
Damon Judges, London, UK
Dennis Wolf, London, UK
Narayan Karunanithy, London, UK Narendra Nath Khanna, New Delhi, India Nils Kucher, Bern, Switzerland Michael Lichtenberg, Arnsberg, Germany Torbjorn Lundh, Gothenburg, Sweden Sahar Mansour, London, UK
Johann Christof Ragg, Berlin, Germany Albert-Adrien Ramelet, Montcherand, Switzerland
Paul Pittaluga, Nice, France Barrie Price, Guildford, UK Nadeem Qazi, London, UK Samina Qureshi, London, UK
London, UK
Albert-Adrien Ramelet, Montcherand,
EDUCATION
www.cxsymposium.com
[email protected]
INNOVATION EVIDENCE CX Symposium
@cxsymposium
